NYSE: DNA
Ginkgo Bioworks Holdings Inc Stock

$5.13-0.15 (-2.84%)
Updated Jan 24, 2022
DNA Price
$5.13
Fair Value Price
N/A
Market Cap
$7.63B
52 Week Low
$4.34
52 Week High
$15.86
P/E
-0.32x
P/B
4.92x
P/S
92.78x
PEG
N/A
Dividend Yield
N/A
Revenue
$165.34M
Earnings
-$231.13M
Gross Margin
61.8%
Operating Margin
-139.17%
Profit Margin
-139.8%
Debt to Equity
0.34
Operating Cash Flow
-$88M
Beta
1.2
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

DNA Overview

Zen Score

High
Medium
Low
Industry Average (19)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DNA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

DNA is poor value based on its book value relative to its share price (4.92x), compared to the US Biotechnology industry average (4.59x)
Valuation
DNA's cash and short-term investments ($1.74B) can cover DNA's cash burn for the next year ($139.68M), even accounting for increasing cash burn (N/A)
Financials
DNA's profit margin has decreased... subscribe to Premium to read more.
Financials
There are 10 more DNA due diligence checks available for Premium users.

DNA News

Valuation

DNA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.32x
Industry
20.6x
Market
34.17x

DNA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.92x
Industry
4.59x
DNA is poor value based... subscribe to Premium to read more.
Valuation

DNA's financial health

Profit margin

Revenue
$77.6M
Net Income
-$101.9M
Profit Margin
-131.3%
DNA's cash and short-term investments... subscribe to Premium to read more.
Financials
DNA's profit margin has decreased... subscribe to Premium to read more.
Financials

Assets to liabilities

Assets
$2.2B
Liabilities
$532.6M
Debt to equity
0.34
DNA's short-term assets ($1.81B) exceed... subscribe to Premium to read more.
Financials
DNA's short-term assets ($1.81B) exceed... subscribe to Premium to read more.
Financials
DNA's debt to equity ratio... subscribe to Premium to read more.
Financials

Cash flow

Operating
-$5.2M
Investing
-$30.5M
Financing
$1.5B
DNA's cash and short-term investments... subscribe to Premium to read more.
Financials

Ginkgo Bioworks Holdings Stock FAQ

What is Ginkgo Bioworks Holdings's quote symbol?

(NYSE: DNA) Ginkgo Bioworks Holdings trades on the NYSE under the ticker symbol DNA. Ginkgo Bioworks Holdings stock quotes can also be displayed as NYSE: DNA.

What is the 52 week high and low for Ginkgo Bioworks Holdings (NYSE: DNA)?

(NYSE: DNA) Ginkgo Bioworks Holdings's 52-week high was $15.86, and its 52-week low was $4.34. It is currently -67.66% from its 52-week high and 18.12% from its 52-week low.

How much is Ginkgo Bioworks Holdings's stock price per share?

(NYSE: DNA) Ginkgo Bioworks Holdings stock price per share is $5.13 today (as of Jan 24, 2022).

What is Ginkgo Bioworks Holdings's Market Cap?

(NYSE: DNA) Ginkgo Bioworks Holdings's market cap is $7.63B, as of Jan 25, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ginkgo Bioworks Holdings's market cap is calculated by multiplying DNA's current stock price of $5.13 by DNA's total outstanding shares of 1,486,734,274.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.